ANGPT1 and Dystonia: Given that the combined treatment of Ang-1 and C16 could synergistically inhibit inflammation [21], we explored the efficacy of C16+Ang-1 as a treatment option for dystonia by assessing the recovery of neuronal morphology and motor functions using an array of histological, immunohistochemical, biochemical, and electrophysiological experiments.